Form 4 for HAE HAEMONETICS CORP
Accepted 2026-05-19 17:37:56 ET · period of report 2026-05-15 · accession 0000313143-26-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 17:37 | 2026-05-15 | HAE | Basil Michelle L | EVP, GC | F - Tax | $56.29 | -2,913 | 40.4K | -7% | -$164.0K | |
| 2026-05-19 17:37 | 2026-05-15 | HAE | Basil Michelle L | EVP, GC | A - Grant | — | +28.4K | 68.8K | +70% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | F | D | 2,913 | $56.29 | 40,405 | D | — | — | (F1) Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. (F2) This number includes unvested RSUs previously reported. |
| 2 | Common | Common Stock | 2026-05-15 | A | A | 28,424 | — | 68,829 | D | — | — | (F3) The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant. (F4) Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. (F2) This number includes unvested RSUs previously reported. |